The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis

MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice

(2019) Ya-Ling Yang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease

(2019) Joeri Lambrecht et al.   EBioMedicine

Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack

(2018) J. Ampuero et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?

(2018) Joeri Lambrecht et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients

(2018) Dan Ye et al.   LIFE SCIENCES

A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat model

(2018) Shanon Seger et al.   PLoS One

Regulation of microRNA function in animals

(2018) Luca F. R. Gebert et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Plasma microRNA: A novel non‑invasive biomarker for HBV‑associated liver fibrosis staging

(2018) Tie‑Zheng Wang et al.   Experimental and Therapeutic Medicine

Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis

(2017) Suxia Bao et al.   Gut and Liver

MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases

(2017) Ya-Ling Yang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients

(2017) O. G. Shaker et al.   JOURNAL OF VIRAL HEPATITIS

Mechanisms of hepatic stellate cell activation

(2017) Takuma Tsuchida et al.   Nature Reviews Gastroenterology & Hepatology

Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma

(2017) Hui Tang et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis

(2017) Joeri Lambrecht et al.   Frontiers in Pharmacology

Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C

(2016) Kentaro Matsuura et al.   HEPATOLOGY

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

(2016) W. Ray Kim et al.   JOURNAL OF HEPATOLOGY

miR-122 expression is not regulated during activation of hepatic stellate cells

(2016) Florian Schueller et al.   JOURNAL OF HEPATOLOGY

MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C

(2016) Kevin Appourchaux et al.   Scientific Reports

GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma

(2015) Yu Zhang et al.   CANCER LETTERS

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Pathobiology of liver fibrosis: a translational success story

(2015) Youngmin A Lee et al.   GUT

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway

(2015) Wonhee Hur et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The carbon tetrachloride model in mice

(2015) D Scholten et al.   LABORATORY ANIMALS

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program

(2015) Shicheng Su et al.   Nature Communications

MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma

(2015) Chen-Dan Zou et al.   Oncotarget

MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis

(2015) Bo-Xun Jin et al.   Scientific Reports

Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma

(2015) Heejin Bang et al.   Cancer Research and Treatment

The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis

(2015) Joeri Lambrecht et al.   Frontiers in Physiology

MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility

(2015) Felice Ho-Ching Tsang et al.   Frontiers of Medicine

Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis

(2014) Guangqin Xiao et al.   HEPATOLOGY

Liver cirrhosis

(2014) Emmanuel A Tsochatzis et al.   LANCET

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver

(2013) Hiroya Yamada et al.   CLINICA CHIMICA ACTA

Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease

(2013) Hisamitsu Miyaaki et al.   LIVER INTERNATIONAL

Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers

(2013) Verena Köberle et al.   PLoS One

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

(2012) Jonel Trebicka et al.   JOURNAL OF HEPATOLOGY

miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression

(2012) Jiang Li et al.   JOURNAL OF HEPATOLOGY

Serum MicroRNA-122 Predicts Survival in Patients with Liver Cirrhosis

(2012) Oliver Waidmann et al.   PLoS One

Extracellular miRNAs: the mystery of their origin and function

(2012) Andrey Turchinovich et al.   TRENDS IN BIOCHEMICAL SCIENCES

Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

(2011) C. C. Pritchard et al.   Cancer Prevention Research

Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?

(2011) José M. Mato et al.   HEPATOLOGY

Haemolysis during Sample Preparation Alters microRNA Content of Plasma

(2011) Michaela B. Kirschner et al.   PLoS One

Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases

(2010) Y. Zhang et al.   CLINICAL CHEMISTRY

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

(2010) Christoph Roderburg et al.   HEPATOLOGY

Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE

(2009) Hui Dong et al.   BMC Medical Genomics

Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells

(2009) Eduardo L.M. Guimarães et al.   JOURNAL OF HEPATOLOGY

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

(2008) Mireen Friedrich–Rust et al.   GASTROENTEROLOGY